Page 1 of Clinical Trials for "Abatacept", 97 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA
Last Updated: April 30, 2012
Condition(s): Rheumatoid Arthritis
2
Completed
Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers
Last Updated: April 11, 2011
Condition(s): Rheumatoid Arthritis
3
Terminated
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis
Last Updated: April 13, 2012
Condition(s): Systemic Lupus Erythematosus
4
Active, not recruiting
Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan
Last Updated: February 15, 2012
Condition(s): Rheumatoid Arthritis
5
Completed
A Study of Abatacept in Patients With Active Ulcerative Colitis
Last Updated: November 4, 2010
Condition(s): Ulcerative Colitis
6
Completed
Methotrexate-Inadequate Response Study
Last Updated: February 28, 2012
Condition(s): Rheumatoid Arthritis (RA)
7
Not yet recruiting
TOward the Lowest Effective DOse of Abatacept or Tocilizumab
Last Updated: March 16, 2012
Condition(s): Rheumatoid Arthritis
8
Terminated
A Study of Abatacept in Patients With Active Crohn's Disease
Last Updated: September 10, 2010
Condition(s): Crohn's Disease
9
Completed
Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past.
Last Updated: November 14, 2011
Condition(s): Rheumatoid Arthritis
10
Completed
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone
Last Updated: May 26, 2011
Condition(s): Systemic Lupus Erythematosus
11
Completed
A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate
Last Updated: February 2, 2012
Condition(s): Rheumatoid Arthritis
12
Active, not recruiting
Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
Last Updated: February 17, 2012
Condition(s): Lupus Nephritis
13
Completed
Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
Last Updated: June 18, 2011
Condition(s): Rheumatoid Arthritis
14
Recruiting
Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA)
Last Updated: February 21, 2012
Condition(s): Rheumatoid Arthritis
15
Completed
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
Last Updated: November 15, 2011
Condition(s): Rheumatoid Arthritis
16
Recruiting
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Last Updated: November 4, 2011
Condition(s): Lupus Nephritis; Lupus Erythematosus, Systemic
17
Completed
Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
Last Updated: December 21, 2010
Condition(s): Rheumatoid Arthritis
18
Recruiting
Abatacept in the Treatment of Uveitis
Last Updated: April 6, 2012
Condition(s): Uveitis
19
Completed
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis
Last Updated: December 30, 2011
Condition(s): Juvenile Rheumatoid Arthritis
20
Recruiting
Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy
Last Updated: October 25, 2011
Condition(s): Urticaria

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Abatacept%22

Page 1 of Clinical Trials for "Abatacept", 97 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About